Marketing and distribution deal reached between HRA Pharma and Nycomed
08 April 2009
Harriet Marshall-Arnold
harriet.marshall-arnold@informa.com
HRA Pharma has signed a marketing and distribution agreement with
Nycomed. The agreement will see Nycomed distribute and market HRA's next-generation emergency contraceptive ellaOne (ulipristal acetate) in the Nordic and Baltic territories, HRA says.
Nycomed, headquartered in Zurich, has...
Please Login to read the full article.